PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver

J Nutr. 2011 Apr 1;141(4):603-10. doi: 10.3945/jn.110.135210. Epub 2011 Feb 23.

Abstract

Emerging evidence suggests that the lack of PPARα enhances hepatic steatosis and inflammation in Ppara-null mice when fed a high-fat diet (HFD). Thus, the aim of this study was to determine whether Ppara-null mice are more susceptible to nonalcoholic steatohepatitis (NASH) than their wild-type (WT) counterparts following short-term feeding with a HFD. Age-matched male WT and Ppara-null mice were randomly assigned to consume ad libitum a standard Lieber-DeCarli liquid diet (STD) (35% energy from fat) or a HFD (71% energy from fat) for 3 wk. Liver histology, plasma transaminase levels, and indicators of oxidative/nitrosative stress and inflammatory cytokines were evaluated in all groups. Levels of lobular inflammation and the NASH activity score were greater in HFD-exposed Ppara-null mice than in the other 3 groups. Biochemical analysis revealed elevated levels of ethanol-inducible cytochrome P450 2E1 and TNFα accompanied by increased levels of malondialdehyde as well as oxidized and nitrated proteins in Ppara-null mice. Elevated oxidative stress and inflammation were associated with activation of c-Jun-N-terminal kinase and p38 kinase, resulting in increased hepatocyte apoptosis in Ppara-null mice fed a HFD. These results, with increased steatosis, oxidative stress, and inflammation observed in Ppara-null mice fed a HFD, demonstrate that inhibition of PPARα functions may increase susceptibility to high fat-induced NASH.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Apoptosis
  • Cytochrome P-450 CYP2E1 / analysis
  • Dietary Fats / administration & dosage*
  • Fatty Liver / pathology
  • Fatty Liver / prevention & control
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipid Peroxidation
  • Liver / pathology
  • Male
  • Mice
  • Nitric Oxide Synthase Type II / analysis
  • Non-alcoholic Fatty Liver Disease
  • Organ Size
  • PPAR alpha / physiology*
  • Proteins / metabolism
  • Tumor Necrosis Factor-alpha / analysis
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Dietary Fats
  • PPAR alpha
  • Proteins
  • Tumor Necrosis Factor-alpha
  • Cytochrome P-450 CYP2E1
  • Nitric Oxide Synthase Type II
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases